ArticleInvestigative ophthalmology & visual science2020

A Clinical Metabolite of Azidothymidine Inhibits Experimental Choroidal Neovascularization and Retinal Pigmented Epithelium Degeneration.

Siddharth Narendran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.